Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Analysis of pairwise correlations in multi-parametric PET/MR data for biological tumor characterization and treatment individualization strategies.

Leibfarth S, Simoncic U, Mönnich D, Welz S, Schmidt H, Schwenzer N, Zips D, Thorwarth D.

Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1199-208. doi: 10.1007/s00259-016-3307-7. No abstract available.

2.

Texture analysis on parametric maps derived from dynamic contrast-enhanced magnetic resonance imaging in head and neck cancer.

Jansen JF, Lu Y, Gupta G, Lee NY, Stambuk HE, Mazaheri Y, Deasy JO, Shukla-Dave A.

World J Radiol. 2016 Jan 28;8(1):90-7. doi: 10.4329/wjr.v8.i1.90.

3.

[18F]-Fluoromisonidazole positron emission tomography/computed tomography visualization of tumor hypoxia in patients with chordoma of the mobile and sacrococcygeal spine.

Cheney MD, Chen YL, Lim R, Winrich BK, Grosu AL, Trofimov AV, Depauw N, Shih HA, Schwab JH, Hornicek FJ, DeLaney TF.

Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1030-6. doi: 10.1016/j.ijrobp.2014.08.016.

4.

Methods to study the tumor microenvironment under controlled oxygen conditions.

Byrne MB, Leslie MT, Gaskins HR, Kenis PJ.

Trends Biotechnol. 2014 Nov;32(11):556-63. doi: 10.1016/j.tibtech.2014.09.006. Review.

5.

Comparing CT perfusion with oxygen partial pressure in a rabbit VX2 soft-tissue tumor model.

Sun CJ, Li C, Lv HB, Zhao C, Yu JM, Wang GH, Luo YX, Li Y, Xiao M, Yin J, Lang JY.

J Radiat Res. 2014 Jan 1;55(1):183-90. doi: 10.1093/jrr/rrt092.

6.

Noise estimation from averaged diffusion weighted images: Can unbiased quantitative decay parameters assist cancer evaluation?

Dikaios N, Punwani S, Hamy V, Purpura P, Rice S, Forster M, Mendes R, Taylor S, Atkinson D.

Magn Reson Med. 2014 Jun;71(6):2105-17. doi: 10.1002/mrm.24877.

7.

Optical imaging of tumor microenvironment.

Wu Y, Zhang W, Li J, Zhang Y.

Am J Nucl Med Mol Imaging. 2013;3(1):1-15.

8.

Current oncologic concepts and emerging techniques for imaging of head and neck squamous cell cancer.

Sadick M, Schoenberg SO, Hoermann K, Sadick H.

GMS Curr Top Otorhinolaryngol Head Neck Surg. 2012;11:Doc08. doi: 10.3205/cto000090.

9.

Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck.

Chawla S, Kim S, Dougherty L, Wang S, Loevner LA, Quon H, Poptani H.

AJR Am J Roentgenol. 2013 Jan;200(1):35-43. doi: 10.2214/AJR.12.9432.

10.

Practical dynamic contrast enhanced MRI in small animal models of cancer: data acquisition, data analysis, and interpretation.

Barnes SL, Whisenant JG, Loveless ME, Yankeelov TE.

Pharmaceutics. 2012;4(3):442-78. doi: 10.3390/pharmaceutics4030442.

11.

Multimodal hypoxia imaging and intensity modulated radiation therapy for unresectable non-small-cell lung cancer: the HIL trial.

Askoxylakis V, Dinkel J, Eichinger M, Stieltjes B, Sommer G, Strauss LG, Dimitrakopoulou-Strauss A, Kopp-Schneider A, Haberkorn U, Huber PE, Bischof M, Debus J, Thieke C.

Radiat Oncol. 2012 Sep 14;7:157. doi: 10.1186/1748-717X-7-157.

12.

An approach to identify, from DCE MRI, significant subvolumes of tumors related to outcomes in advanced head-and-neck cancer.

Wang P, Popovtzer A, Eisbruch A, Cao Y.

Med Phys. 2012 Aug;39(8):5277-85. doi: 10.1118/1.4737022.

13.

Simultaneous PET-MRI in oncology: a solution looking for a problem?

Yankeelov TE, Peterson TE, Abramson RG, Izquierdo-Garcia D, Arlinghaus LR, Li X, Atuegwu NC, Catana C, Manning HC, Fayad ZA, Gore JC.

Magn Reson Imaging. 2012 Nov;30(9):1342-56. doi: 10.1016/j.mri.2012.06.001. Review. Erratum in: Magn Reson Imaging. 2013 Jun;31(5):796. Garcia-Izquierdo, David [corrected to Izquierdo-Garcia, David].

14.

Correlation of a priori DCE-MRI and (1)H-MRS data with molecular markers in neck nodal metastases: Initial analysis.

Jansen JF, Carlson DL, Lu Y, Stambuk HE, Moreira AL, Singh B, Patel SG, Kraus DH, Wong RJ, Shaha AR, Shah JP, Shukla-Dave A.

Oral Oncol. 2012 Aug;48(8):717-22. doi: 10.1016/j.oraloncology.2012.02.001.

15.

MRI of metastasis-permissive microenvironments.

Penet MF, Chen Z, Bhujwalla ZM.

Future Oncol. 2011 Nov;7(11):1269-84. doi: 10.2217/fon.11.114. Review.

16.

Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases.

Shukla-Dave A, Lee NY, Jansen JF, Thaler HT, Stambuk HE, Fury MG, Patel SG, Moreira AL, Sherman E, Karimi S, Wang Y, Kraus D, Shah JP, Pfister DG, Koutcher JA.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1837-44. doi: 10.1016/j.ijrobp.2011.03.006.

17.

The promise of dynamic contrast-enhanced imaging in radiation therapy.

Cao Y.

Semin Radiat Oncol. 2011 Apr;21(2):147-56. doi: 10.1016/j.semradonc.2010.11.001. Review.

18.

Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.

Jansen JF, Schöder H, Lee NY, Stambuk HE, Wang Y, Fury MG, Patel SG, Pfister DG, Shah JP, Koutcher JA, Shukla-Dave A.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):299-307. doi: 10.1016/j.ijrobp.2010.11.022.

19.

Non-invasive imaging of angiogenesis in head and neck squamous cell carcinoma.

Jansen JF, Koutcher JA, Shukla-Dave A.

Angiogenesis. 2010 Jun;13(2):149-60. doi: 10.1007/s10456-010-9167-z. Review.

20.

Non-gaussian analysis of diffusion-weighted MR imaging in head and neck squamous cell carcinoma: A feasibility study.

Jansen JF, Stambuk HE, Koutcher JA, Shukla-Dave A.

AJNR Am J Neuroradiol. 2010 Apr;31(4):741-8. doi: 10.3174/ajnr.A1919.

Items per page

Supplemental Content

Support Center